Levocetirizine Dihydrochloride

Product NDC
60505-3713
11-digit product format
605053713
Labeler code
60505
Product ID
60505-3713_d10fec00-394e-932f-f237-68b14c9c3505
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Levocetirizine Dihydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
Apotex Corp.
Application
ANDA203027
Marketing category
ANDA
Marketing start
2015-02-13
Marketing end
2021-03-01
Substance
LEVOCETIRIZINE DIHYDROCHLORIDE
Active strength
5 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
36cf9111-9cc4-8f59-a74c-0c1cfbd4a760Product name720190702

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60505-3713-9EA - Each60505-3713e1375854-5193-4a4e-a29d-105d0b2c2f9d12016-02-04

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
855172levocetirizine dihydrochloride 5 MG Oral TabletPSN2042b8be-c8c1-418e-ad48-851ea61b27268
855172levocetirizine dihydrochloride 5 MG Oral TabletSCD2042b8be-c8c1-418e-ad48-851ea61b27268
855172levocetirizine dihydrochloride 5 MG 24 HR Oral TabletSY2042b8be-c8c1-418e-ad48-851ea61b27268
855172levocetirizine dihydrochloride 5 MG Oral TabletPSN1efcf912-1187-4d69-895c-30d363e5eb7a1
855172levocetirizine dihydrochloride 5 MG Oral TabletSCD1efcf912-1187-4d69-895c-30d363e5eb7a1
855172levocetirizine dihydrochloride 5 MG 24 HR Oral TabletSY1efcf912-1187-4d69-895c-30d363e5eb7a1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
60505-3713-96050537130990 TABLET in 1 BOTTLE (60505-3713-9) 90 tablet2015-02-132021-03-01NoNoCurrent